Insider · CIK 0001963901
Brian Taylor Slingsby
Files at MLYS (Mineralys Therapeutics, Inc.). First filing Apr 25, 2025, latest Sep 24, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MLYS: Mineralys Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | Mineralys Therapeutics, Inc. | $3.0M 104,320 shares | -1% | +31% from low-38% from high | |
| 55Moderate | Mineralys Therapeutics, Inc. | $3.5M 259,259 shares | +3% | +54% from low-10% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | MLYS Mineralys Therapeutics, Inc. | SOpen-market sale Common Stockindirect: See footnote | -104,320 | $28.81 | $3.0M | 7,805,718 | 18 d ago |
| Mar 13, 2025 | MLYS Mineralys Therapeutics, Inc. | POpen-market purchase Common Stockindirect: See Footnote | +259,259 | $13.50 | $3.5M | 8,903,838 | Apr 25, 2025 |
| Feb 13, 2025 | MLYS Mineralys Therapeutics, Inc. | AGrant or award Stock Optionderivative | +32,900 | $0.00 | $0 | 32,900 | Feb 24, 2025 |
| Feb 13, 2025 | MLYS Mineralys Therapeutics, Inc. | JOther Stock Optionderivative | -32,900 | $0.00 | $0 | 0 | Feb 24, 2025 |
| Feb 13, 2025 | MLYS Mineralys Therapeutics, Inc. | JOther Stock Optionderivativeindirect: See footnote | +32,900 | $0.00 | $0 | 32,900 | Feb 24, 2025 |
| May 22, 2024 | MLYS Mineralys Therapeutics, Inc. | JOther Stock Optionderivative | -22,000 | $0.00 | $0 | 0 | Jan 7, 2025 |
| May 22, 2024 | MLYS Mineralys Therapeutics, Inc. | JOther Stock Optionderivativeindirect: See footnote | +22,000 | $0.00 | $0 | 22,000 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.